Figure 1
From: Disturbance of Plasma Lipid Metabolic Profile in Guillain-Barre Syndrome
Targeted metabolomics profiles in the GBS patients, the multiple sclerosis (MS) patients, and the healthy controls (control). Extracted plasma from GBS patients (n = 38), MS patients (n = 22) and healthy controls (n = 40) were analyzed by LC-MS/MS and FIA-MS/MS in electrospray positive and negative ion mode. (A) The orthogonal partial least squares discriminant analysis (OPLS-DA) demonstrates a clear separation of metabolites between GBS, MS, and control cases (R2 = 0.503, Q2 = 0.338). (B) A Venn diagram was used to visualize the number of extremely different metabolites (p < 0.05) after one-way ANOVA analysis with Tukey’s post hoc test with false discovery rate (FDR) correction between the GBS and MS patients and the controls.
